Inventor
RAVINDRA MAJETI
Inventor
US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides23%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
Y02ATechnologies for adaptation to climate change9%
C12NMicroorganisms or enzymes7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
12,371,469Therapeutic antigen binding proteins specific for CD93 and methods of use thereof202512,274,746Dosing parameters for CD47 targeting therapies to hematologic malignancies202512,258,399Methods for achieving therapeutically effective doses of anti-CD47 agents202512,258,403Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody202512,194,093Dosing parameters for CD47 targeting therapies to hematologic malignancies202512,162,939Methods for manipulating phagocytosis mediated by CD47202411,807,684Humanized and chimeric monoclonal antibodies to CD47202311,795,223Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia202311,780,918Markers of acute myeloid leukemia stem cells202311,773,165Markers of acute myeloid leukemia stem cells202311,760,810Modified immunoglobulin hinge regions to reduce hemagglutination202311,760,800Markers of acute myeloid leukemia stem cells202311,718,670Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer202311,603,404Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody202311,518,806Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody202211,472,878Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer202211,377,495Markers of acute myeloid leukemia stem cells202211,141,480Dosing parameters for CD47 targeting therapies to hematologic malignancies202111,136,391Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNIV LELAND STANFORD JUNIOR (18)· patent assignee history
2021–2023Patents assigned to FORTY SEVEN INC (2)· patent assignee history
2021–2025Based in US· patent location history
2025Patents assigned to FORTY SEVEN LLC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 18 | 2021–2025 |
| FORTY SEVEN INC | 2 | 2021–2023 |
| FORTY SEVEN LLC | 2 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 19 | 2021–2025 |